Información del producto
ML184 is a synthetic cannabinoid drug that has been found to have low potency and activated properties. ML184 binds to the CB2 receptor, which is primarily expressed in immune cells and microglia. The binding of ML184 to the CB2 receptor may be involved in the regulation of transcriptional regulation, biological functions, and autoimmune diseases. It also has agonist binding site activity for the endocannabinoid system and can be used as an anti-inflammatory agent. This drug has also been shown to have anticancer effects, which may be due to its ability to induce apoptosis in cancer cells.
Propiedades químicas
Consulta técnica sobre: 3D-UGB57210 ML184
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
